课题基金 / 基金详情

Metabolism and Physiological functions of endogenous D-serine

Metabolism and Physiological functions of endogenous D-serine
内源性D-丝氨酸的代谢和生理功能
批准号:
07557242
负责人:
NISHIKAWA Toru
金额:
$3.01万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

NISHIKAWA Toru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To obtain an insight into physiological and pathophysiological role of endogenous D-serine in higher brain functions, we have investigated the metabolism of D-serine in the rat and human brain tissues. Substantial concentration of D-serine has been detected in the extracellular fluid of the frontal cortex and striatum of the rat by an in vivo microdialysis technique. Neither calcium ion-free condition nor perfusion of tetrodotoxin reduced extracellular D-serine content in the frontal cortex and a depolarization agent, veratrin, caused an increase in the extracellular release of glutamate, but not D-serine. These data suggest that extracellular D-serine could be liberated from glial cells. [3H]D-Serine was found to be taken up into the cortical and cerebellar P2 franction and the C6 glioma cells in a temperature-and sodium-dependent and saturable manner, indicating the presence a transport system for D-serine. In addition to the glycine modulatory site of the NMDA receptor at which D-serine acts as a potent agonist, [3H]D-serine has also been shown to bind to a novel site in the brain tissues. Moreover, we have observed a profound reduction of cortical D-serine contents in the patients with non-ketotic hyperglycinemia lacking activity of glycine cleavage system (GCS) and in the animal treated with an inhibitor of GCS,cysteamine. Systemic administration of a high amount of L-serine produced a marked increase in cortical D-serine concentrations in the infant rats, vice versa. The present findings further support the view that endogenous D-serine may be involved in the synaptic transmission mediated by the NMDA receptor and other unknown receptor sites. The synthesis of D-serine might be closely related to the metabolism of L-serine and glycine.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
Kumashiro S, Hashimoto A and Nishikawa T.: "Free D-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases." Brain Res.681. 117-125 (1995)
Kumashiro S、Hashimoto A 和 Nishikawa T.:“患有或不患有神经精神疾病的个体死后大脑和脊髓中的游离 D-丝氨酸。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsui T,Sekiguchi M,Hashimoto A,Tomita U,Nishikawa T and Wada K: "Functional comparison of D-serine and glycine in rodents : The effects on cloned NMDA receptors and the extracellular concentration" J Neurochem. 65. 454-458 (1995)
Matsui T、Sekiguchi M、Hashimoto A、Tomita U、Nishikawa T 和 Wada K:“D-丝氨酸和甘氨酸在啮齿动物中的功能比较:对克隆 NMDA 受体和细胞外浓度的影响”J Neurochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
西川 徹: "KEY WORD 1997-‘98 精神(「興奮性アミノ酸と精神分裂症」)" 先端医学社, 268(2) (1997)
Toru Nishikawa:“关键词 1997-98 精神病学(“兴奋性氨基酸和精神分裂症”)”仙台医学社,268(2)(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi K, et al.: "In vivo evidence for the link between L-and D-serine metabolism in rat cerebral cortex" J Neurochem. 69. 1286-1290 (1997)
Takahashi K 等人:“大鼠大脑皮层 L-和 D-丝氨酸代谢之间联系的体内证据”J Neurochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
62
    Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
    • 批准号:
      21390330
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2009
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
    • 批准号:
      19390302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    Elucidation of molecular pathomechanisms of schizophrenia
    • 批准号:
      17025016
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $68.22万
    • 财政年份:
      2005
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
    • 批准号:
      14207040
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.2万
    • 财政年份:
      2002
    • 负责人:
      NISHIKAWA Toru
    • 依托单位:
    海外基金